Development of the First-in-Class FEM1B-Recruiting Histone Deacetylase Degraders
Felix Feller(University of Bonn), Finn K. Hansen(University of Bonn)
Cited by 13
Related Papers
Difluoromethyl-1,3,4-oxadiazoles Are Selective, Mechanism-Based, and Essentially Irreversible Inhibitors of Histone Deacetylase <b>6</b>
|Journal of Medicinal Chemistry|2023|46
Development of Fluorinated Peptoid-Based Histone Deacetylase (HDAC) Inhibitors for Therapy-Resistant Acute Leukemia
|Journal of Medicinal Chemistry|2022|32
Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy
|Pharmaceuticals|2023|28
Exploring Alternative Zinc-Binding Groups in Histone Deacetylase (HDAC) Inhibitors Uncovers <b>DS-103</b> as a Potent Ethylhydrazide-Based HDAC Inhibitor with Chemosensitizing Properties
|Journal of Medicinal Chemistry|2025|12
A Novel Zinc Binding Group for HDAC6 Inhibition
|The FASEB Journal|2022|11